article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

After graduating, Miles went on to work as a scientist on AstraZeneca’s Research and Development graduate programme, working on projects in biocatalysis, computational organic chemistry and machine learning for drug discovery. The ability to integrate these domains, including chemistry, is key for success in this field.

article thumbnail

The Nobel Prize winning power of click chemistry

Drug Discovery World

link] key-initiatives/moonshot-cancer- initiative/blue-ribbon-panel/blue- ribbon-panel-report-2016.pdf About the author: José Mejía Oneto, Founder and CEO of Shasqi, has a background in orthopaedic surgery and organic chemistry. Baskin, Prescher, Laughlin, Agard, Chang, Miller, Lo, Codelli, Bertozzi. Proc Natl Acad Sci U S A.